128 related articles for article (PubMed ID: 20887219)
1. Historical perspective on HIV‐exposed seronegative individuals: has nature done the experiment for us?
Shearer G; Clerici M
J Infect Dis; 2010 Nov; 202 Suppl 3():S329-32. PubMed ID: 20887219
[TBL] [Abstract][Full Text] [Related]
2. Resistance to HIV-1 infection: lessons learned from studies of highly exposed persistently seronegative (HEPS) individuals.
Kulkarni PS; Butera ST; Duerr AC
AIDS Rev; 2003; 5(2):87-103. PubMed ID: 12876898
[TBL] [Abstract][Full Text] [Related]
3. Cohorts for the study of HIV‐1-exposed but uninfected individuals: benefits and limitations.
Horton RE; McLaren PJ; Fowke K; Kimani J; Ball TB
J Infect Dis; 2010 Nov; 202 Suppl 3():S377-81. PubMed ID: 20887228
[TBL] [Abstract][Full Text] [Related]
4. Genetic and immune determinants of immune activation in HIV-exposed seronegative individuals and their role in protection against HIV infection.
Fenizia C; Rossignol JF; Clerici M; Biasin M
Infect Genet Evol; 2018 Dec; 66():325-334. PubMed ID: 29258786
[TBL] [Abstract][Full Text] [Related]
5. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1.
Liu H; Hwangbo Y; Holte S; Lee J; Wang C; Kaupp N; Zhu H; Celum C; Corey L; McElrath MJ; Zhu T
J Infect Dis; 2004 Sep; 190(6):1055-8. PubMed ID: 15319853
[TBL] [Abstract][Full Text] [Related]
6. [Soluble factors with inhibitory activity against type 1 Human Immunodeficiency Virus].
Zapata W; Montoya CJ; Rugeles MT
Biomedica; 2006 Sep; 26(3):451-66. PubMed ID: 17176009
[TBL] [Abstract][Full Text] [Related]
7. Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women.
Hirbod T; Broliden K
J Intern Med; 2007 Jul; 262(1):44-58. PubMed ID: 17598814
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity in exposed uninfected individuals.
Lopalco L; Pastori C; Barassi C; Furci L; Burastero S; Lillo F; Boeri E; Soldini L; Tambussi G; Lazzarin A; Beretta A; Siccardi AG
J Biol Regul Homeost Agents; 1997; 11(1-2):27-31. PubMed ID: 9418157
[TBL] [Abstract][Full Text] [Related]
9. Innate molecular and anatomic mucosal barriers against HIV infection in the genital tract of HIV‐exposed seronegative individuals.
Broliden K
J Infect Dis; 2010 Nov; 202 Suppl 3():S351-5. PubMed ID: 20887223
[TBL] [Abstract][Full Text] [Related]
10. Stromal cell-derived factor 1 (SDF1) genetic polymorphism in a sample of healthy individuals, seronegative individuals exposed to human immunodeficiency virus type 1 (HIV-1) and patients infected with HIV-1 from the Brazilian population.
Reiche EM; Watanabe MA; Bonametti AM; Morimoto HK; Morimoto AA; Wiechmann SL; Matsuo T; Miranda HC; Reiche FV; Oliveira KB
Int J Immunogenet; 2006 Apr; 33(2):127-33. PubMed ID: 16611258
[TBL] [Abstract][Full Text] [Related]
11. Humoral immunity in HIV-1 exposure: cause or effect of HIV resistance?
Lopalco L
Curr HIV Res; 2004 Apr; 2(2):127-39. PubMed ID: 15078177
[TBL] [Abstract][Full Text] [Related]
12. [Mechanisms of resistance to sexual transmission of HIV-1].
Eberhard A; Ponceau B; Biron F; Verrier B
Med Mal Infect; 2005 Nov; 35(11):517-24. PubMed ID: 16253454
[TBL] [Abstract][Full Text] [Related]
13. Twenty years of therapy for HIV-1 infection.
Pomerantz RJ; Horn DL
Nat Med; 2003 Jul; 9(7):867-73. PubMed ID: 12835707
[TBL] [Abstract][Full Text] [Related]
14. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of human natural resistance to HIV: a summary of ten years of research in the Colombian population.
Rugeles MT; Velilla PA; Montoya CJ
Biomedica; 2011 Jun; 31(2):269-80. PubMed ID: 22159545
[TBL] [Abstract][Full Text] [Related]
16. Genetic variability at the TREX1 locus is not associated with natural resistance to HIV-1 infection.
Sironi M; Biasin M; Forni D; Cagliani R; De Luca M; Saulle I; Caputo SL; Mazzotta F; Macias J; Pineda JA; Caruz A; Clerici M
AIDS; 2012 Jul; 26(11):1443-5. PubMed ID: 22526516
[TBL] [Abstract][Full Text] [Related]
17. Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection.
Herrero R; Real LM; Rivero-Juárez A; Pineda JA; Camacho Á; Macías J; Laplana M; Konieczny P; Márquez FJ; Souto JC; Soria JM; Saulle I; Lo Caputo S; Biasin M; Rivero A; Fibla J; Caruz A
Genes Immun; 2015 Mar; 16(2):134-41. PubMed ID: 25569262
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between virus and host innate immunity in pediatric HIV-1 infection and disease progression.
Freguja R; Gianesin K; Zanchetta M; De Rossi A
New Microbiol; 2012 Jul; 35(3):249-57. PubMed ID: 22842595
[TBL] [Abstract][Full Text] [Related]
19. Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility.
Liu H; Carrington M; Wang C; Holte S; Lee J; Greene B; Hladik F; Koelle DM; Wald A; Kurosawa K; Rinaldo CR; Celum C; Detels R; Corey L; McElrath MJ; Zhu T
J Infect Dis; 2006 Mar; 193(5):698-702. PubMed ID: 16453266
[TBL] [Abstract][Full Text] [Related]
20. Stromal cell-derived factor (SDF) 1-3'A polymorphism may play a role in resistance to HIV-1 infection in seronegative high-risk Thais.
Tiensiwakul P
Intervirology; 2004; 47(2):87-92. PubMed ID: 15192272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
